Jason is a scientist entrepreneur passionate about translating innovative technologies into more effective therapies and better patient outcomes. He founded Start Codon to identify and recruit high-potential and disruptive healthcare startups worldwide, seed fund them, and leverage the exceptional resources of the Cambridge (UK) Cluster with an aim to minimise risk and drive their success.
Previously, Jason was CEO of Cambridge Epigenetix which has developed a proprietary epigenetic biomarker discovery platform for the development of new diagnostic assays and the identification of novel drug targets. While at Cambridge Epigenetix, he transformed the research tools company into a leading liquid biopsy player and led two successful fundraises (Series B and C) for a total of $49.8m.
Jason was awarded a Marshall Scholarship to obtain his PhD in Medicine from the University of Cambridge with a focus on the molecular mechanisms regulating vascular remodelling within coronary artery bypass grafts. He has a BSc (Summa Cum Laude) in Molecular Biology and Chemistry from Tulane University.